Correction : A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
BMC medicine - 20(2022), 1 vom: 08. Dez., Seite 478 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kinoshita, Taku [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 11.12.2022 published: Electronic ErratumFor: BMC Med. 2022 Sep 27;20(1):342. - PMID 36163020 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s12916-022-02695-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34994766X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34994766X | ||
| 003 | DE-627 | ||
| 005 | 20231226043837.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12916-022-02695-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1166.xml |
| 035 | |a (DE-627)NLM34994766X | ||
| 035 | |a (NLM)36482439 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kinoshita, Taku |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction |b A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.12.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumFor: BMC Med. 2022 Sep 27;20(1):342. - PMID 36163020 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Shinoda, Masahiro |e verfasserin |4 aut | |
| 700 | 1 | |a Nishizaki, Yasuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Shiraki, Katsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Hirai, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Kichikawa, Yoshiko |e verfasserin |4 aut | |
| 700 | 1 | |a Tsushima, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Shinkai, Masaharu |e verfasserin |4 aut | |
| 700 | 1 | |a Komura, Naoyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshida, Kazuo |e verfasserin |4 aut | |
| 700 | 1 | |a Kido, Yasutoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Kakeya, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Uemura, Naoto |e verfasserin |4 aut | |
| 700 | 1 | |a Kadota, Junichi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC medicine |d 2003 |g 20(2022), 1 vom: 08. Dez., Seite 478 |w (DE-627)NLM143503421 |x 1741-7015 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2022 |g number:1 |g day:08 |g month:12 |g pages:478 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12916-022-02695-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2022 |e 1 |b 08 |c 12 |h 478 | ||